Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HORWITZ

Showing results (631-640 of 831) with videos related to

Pageof 84
Sort By:
British Journal of Haematology|October 3, 2006
Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignanciesXiaohua Chen, Gregory A Hale, Raymond Barfield, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groupsHoward D Thames, Deborah A Kuban, Michelle L DeSilvio, et al.
The Journal of Urology|February 16, 2005
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysisEric M Horwitz, Howard D Thames, Deborah A Kuban, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 3, 1999
Depressive and disruptive disorders and mental health service utilization in children and adolescentsP Wu, C W Hoven, H R Bird, et al.
Journal of Abnormal Child Psychology|July 2, 2016
Comparing the CASI-4R and the PGBI-10 M for Differentiating Bipolar Spectrum Disorders from Other Outpatient Diagnoses in YouthMian-Li Ong, Eric A Youngstrom, Jesselyn Jia-Xin Chua, et al.
Biological Psychiatry|October 4, 2002
Overcoming barriers to reducing the burden of affective disordersKenneth B Wells, Jeanne Miranda, Mark S Bauer, et al.
American Journal of Cancer Research|October 22, 2011
Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the MesenkillersGiulia Grisendi, Rita Bussolari, Elena Veronesi, et al.
Blood|March 8, 2012
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphomaSteven M Horwitz, Youn H Kim, Francine Foss, et al.
Leukemia|September 27, 2014
Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesisJ H Schatz, S M Horwitz, J Teruya-Feldstein, et al.
British Journal of Haematology|May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphomaRobert Stuver, Steven M Horwitz, Ranjana H Advani, et al.
Pageof 84

Showing results (631-640 of 831) with videos related to

Sort By:
Pageof 84
British Journal of Haematology|October 3, 2006
Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignanciesXiaohua Chen, Gregory A Hale, Raymond Barfield, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groupsHoward D Thames, Deborah A Kuban, Michelle L DeSilvio, et al.
The Journal of Urology|February 16, 2005
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysisEric M Horwitz, Howard D Thames, Deborah A Kuban, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 3, 1999
Depressive and disruptive disorders and mental health service utilization in children and adolescentsP Wu, C W Hoven, H R Bird, et al.
Journal of Abnormal Child Psychology|July 2, 2016
Comparing the CASI-4R and the PGBI-10 M for Differentiating Bipolar Spectrum Disorders from Other Outpatient Diagnoses in YouthMian-Li Ong, Eric A Youngstrom, Jesselyn Jia-Xin Chua, et al.
Biological Psychiatry|October 4, 2002
Overcoming barriers to reducing the burden of affective disordersKenneth B Wells, Jeanne Miranda, Mark S Bauer, et al.
American Journal of Cancer Research|October 22, 2011
Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the MesenkillersGiulia Grisendi, Rita Bussolari, Elena Veronesi, et al.
Blood|March 8, 2012
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphomaSteven M Horwitz, Youn H Kim, Francine Foss, et al.
Leukemia|September 27, 2014
Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesisJ H Schatz, S M Horwitz, J Teruya-Feldstein, et al.
British Journal of Haematology|May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphomaRobert Stuver, Steven M Horwitz, Ranjana H Advani, et al.
Pageof 84